Search results for Hanmi Pharmaceutical
AI & Enterprise
MegazoneCloud to build Hanmi Pharm quality assurance AI agent using AIR Studio
MegazoneCloud said on Sept. 7 it will build an AI agent to automate quality assurance work at Hanmi Pharmaceutical, based on its enterprise AI OS, AIR Studio. The project is being carried out under the AX One-Stop Voucher Support Program run by the Ministry of Science and ICT and the National IT Industry Promotion Agency. The agent will search and summarise more than 4,000 quality documents and compare them with the latest regulations.
AI & Enterprise
Megazone to support Hanmi Science AX in AI-based work innovation partnership
Megazone, the parent company of AI and cloud firm MegazoneCloud, agreed to cooperate with Hanmi Science to strengthen the company’s overall digital innovation capabilities, it said on Sunday. Under the deal, the two sides plan to jointly pursue AX-based work innovation tasks, cooperation to enhance digital transformation capabilities and other AI and digital innovation initiatives. They also plan to form a working-level consultative body to identify projects and review execution plans.
Finance
Mirae Asset Management lists TIGER Technology Transfer Bio Active ETF
Mirae Asset Management said it listed the TIGER Technology Transfer Bio Active ETF on the Korea Exchange on March 17. The active ETF uses the KRX Technology Transfer Bio Index announced by the Korea Exchange as its benchmark and mainly invests in listed KOSDAQ bio stocks. It focuses on the technology transfer, or license-out, theme. The initial portfolio includes biotech firms such as LikaChem Bio, OliX and ABL Bio, which account for about 86.8 percent.
